Overview

Hyperkalemia is a common electrolyte disorder, especially in patients with chronic kidney disease, heart failure, and diabetes mellitus. Preventing and managing hyperkalemia requires an interprofessional team-based approach, including initiation of pharmacologic treatment agents to correct potassium levels, dietary counseling, and medication adjustments. Conventional treatment options for hyperkalemia have provided limited benefit and have been associated with serious adverse events. However, novel potassium binding agents have emerged, that are able to significantly lower potassium and offer an improved tolerability profile. Pharmacists are optimally positioned to help the interprofessional team integrate these agents into clinical practice and overcome any challenges that may arise. The goal of this educational curriculum is to improve awareness of new and emerging agents for the treatment of hyperkalemia to enable pharmacists to decrease the burden of hyperkalemia across the continuum of care. 

View All Speakers

Speakers

Kristy Greene, PharmD, BCPS, BCCCP



View Full Bio

Katherine DiPalo, PharmD, BCACP, BCGP



View Full Bio

Darren Grabe, PharmD



View Full Bio

Accreditation

CPE

In support of improving patient care, Creative Educational Concepts is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

This application-based activity is approved for 1.50 contact hours (0.150 CEUs) of continuing pharmacy education credit (UAN JA0007101-0000-18-015-L01-P).

Other

Creative Educational Concepts, Inc. certifies this activity for 1.50 hours of participation.

Acknowledgement

Presented by Creative Educational Concepts, Inc. (CEC) and supported through an independent educational grant from AstraZeneca.